1Rahman M, Fu P, Sehgal AR, et al. Interdialytic weight gain, compliance with dialysis regimen, and age are independent predictors of blood pressure in hemodialysis patients[ J]. Am J Kidney Dis, 2000,35 (2) :257-265.
2Savazzi GM, Cusmano F, Bergamaschi E, et al. Hypertension as an etiopathological factor in the development of cerebral atrophy in hemodialyzed patients[ J]. Nephren, 1999,81 ( 1 ) : 17-24.
3Agarwal R. How to diagnose hypertension in hemodialysis patients[J] ? Minerva Urol Nefrol,2002,54(3) : 149-156.
4Rahman M, Smith MC. Hypertension in hemodialysis patients[J]. Curr Hypertens Rep, 2001,3 (6) : 496-502.
5Nishikimi T, Futoo Y,Tamano K, et al. Plasma brain natriuretic peptide levels in chronic hemodialysis patients: influence of coronary artery disease[J] .Am J Kidney Dis,2001,37(6) : 1201-1208.
6Boero R, Pignataro A, Ferro M, et al. Sympathetic nervous system and chronic renal failure[J]. Clin Exp Hypertens,2001,23(1-2) :69-75.
7Xiao S, Wagner L, Mahaney J. Uremic levels of urea inhibit L-arginine transport in cultured endothelial cells[Jl. Am J Physiol Renal Physiol,2001,280(6) : F989-995.
8Fleck C, Janz A, Schweitzer F, et al. Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in renal failure patients [ J ]. Kidney Int Suppl, 2001,78 : S 14-18.
9Surdacki A, Sulowicz W,Wieczorek Surdacka E, et al. Effect of a hemodialysis session on plasma levels of endothelin- 1 in hypertensive and normotensive subjects with end-stage renal failure[ J]. Nephron, 1999,81(1) :31-36.
10Kang ES, Wang YB, Cardenas R, et al. Biphasic changes in nitric oxidege neration in hemodialyzed patients with end-stage renal disease treated with recombinant human erythropoietin [ J ]. Am J Med Sci, 2000,319(3) : 149-157.
